Core Insights - The four main areas of focus for institutions are technology (including AI), biotechnology, new consumption, and high-end manufacturing [1] - The Hong Kong IPO market is expected to remain active, with predictions of 90 to 100 companies going public in 2025, raising over HKD 200 billion [1] - The sentiment of foreign investors towards the Chinese market is improving, with significant participation in IPOs [2] Group 1: IPO Market Dynamics - The IPO pipeline is strong, with approximately 288 companies waiting for approval as of mid-July [3] - Morgan Stanley's analysis indicates that cornerstone investors contributed 42% of IPO financing this year, with two-thirds coming from overseas [3] - The recent secondary listing of CATL in Hong Kong marked a peak in the IPO market, raising approximately HKD 307.2 billion [2] Group 2: Investment Trends - AI-related hardware and software, innovative pharmaceuticals, and high-end manufacturing are leading investment themes [5] - The innovative drug sector has seen significant interest from foreign investors, with over USD 1 billion in overseas licensing orders becoming commonplace [5][6] - The share of Chinese assets in overseas pharmaceutical business development (BD) has increased to around 45% in the first half of this year, up from 28% last year [7] Group 3: New Consumption Sector - New consumption companies, including those in the food and beverage sector, are gaining traction in the IPO market, with several brands already listed [8] - Upcoming IPOs in the new consumption space include brands like 52TOYS and TOP TOY, reflecting a diverse interest in consumer goods [8] - The performance of new consumption stocks has been impressive, with significant price increases noted [6]